Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

105.26 -0.35 (-0.33%)
Streaming Delayed Price Updated: 12:04 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
57 58 Next >
News headline image
Lumentum Lights Up on the AI and ML Surge
Optical and photonics manufacturer Lumentum Holdings Inc. (NASDAQ: LITE) provides optical components and lasers to data centers, cloud providers, telecoms 
Via MarketBeat
Topics Artificial Intelligence
News headline image
2 Magnificent Dividend Stocks to Buy Hand Over Fist in October ↗
These two healthcare stocks are reliable passive income vehicles. 
Via The Motley Fool
News headline image
Looking Into Abbott Laboratories's Recent Short Interest ↗
 
Via Benzinga
News headline image
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $2,900 Today ↗
 
Via Benzinga
News headline image
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation ↗
These companies are helping change medicine; they could make boatloads of money along the way. 
Via The Motley Fool
News headline image
Abbott Laboratories Unusual Options Activity ↗
 
Via Benzinga
News headline image
Looking At Abbott Laboratories's Recent Unusual Options Activity ↗
 
Via Benzinga
News headline image
Abbott Stock: Bear vs. Bull ↗
Abbott is a favorite of income-oriented investors, but is the price right? 
Via The Motley Fool
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Abbott Laboratories And More On CNBC's 'Final Trades' ↗
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named Innovator U.S. 
Via Benzinga
News headline image
Want $500 in Passive Income? Invest $3,500 Into These 3 Dividend Stocks and Wait 4 Years ↗
A basket of passive income opportunities in oil and gas, renewable energy, and healthcare. 
Via The Motley Fool
News headline image
Why Abbott Says It Won't Be A Casualty Of The Weight-Loss Battle ↗
Abbott and Dexcom stocks have tumbled as GLP-1 drugs have gripped the nation. 
Via Investor's Business Daily
News headline image
2 Stocks to Benefit from the Aging Population
The growth of the aging population is entirely predictable, which makes now an ideal time to consider these two health and wellness stocks 
Via MarketBeat
Topics Retirement
News headline image
P/E Ratio Insights for Abbott Laboratories ↗
 
Via Benzinga
News headline image
This Is What Whales Are Betting On Abbott Laboratories ↗
 
Via Benzinga
News headline image
(ABT) - Analyzing Abbott Laboratories's Short Interest ↗
 
Via Benzinga
News headline image
3 Best Stocks to Buy in September and Hold Forever ↗
Healthcare blue chip stocks with proven track records can be excellent long-term investments. 
Via The Motley Fool
News headline image
3 Unstoppable Nasdaq 100 Stocks Just Waiting to Be Bought ↗
Tech stocks were the primary fuel for a decades-long bull market, and these three Nasdaq stocks to buy can lead the market forward. 
Via InvestorPlace
News headline image
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year ↗
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday. 
Via Benzinga
News headline image
Apple Taps Seasoned Executive To Head 'Secret' Team Developing Glucose Monitoring Device - Stocks To Watch ↗
Apple Inc (NASDAQ: AAPL) has appointed Tim Millet, a seasoned executive with a background in iPhone and Mac chip technology, to oversee its secretive team dedicated to developing a noninvasive blood... 
Via Benzinga
News headline image
If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today ↗
 
Via Benzinga
News headline image
Is Abbott Laboratories a Buy? ↗
If you're willing to invest with the right mindset, it could be a great option. 
Via The Motley Fool
News headline image
2 Dividend Kings to Buy on the Dip and Hold Forever ↗
Don't ignore these stocks just because the rest of the market is. 
Via The Motley Fool
News headline image
Why Jim Cramer Warns Investors To Avoid This Stock Up Over 90% This Year ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said UiPath Inc. (NYSE: PATH) is a "decent" stock. Cramer said the company is not making money, and he doesn’t recommend stocks that don’t make money. 
Via Benzinga
News headline image
Could Abbott Laboratories Stock Help You Become a Millionaire? ↗
One promising area of its business is diabetes care, which experienced significant growth this year. 
Via The Motley Fool
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Less Is More: Abbott’s Approach to Packaging Innovation
Via ACCESSWIRE
News headline image
3 No-Brainer Dividend Stocks to Buy No Matter What the Market Is Doing ↗
You'll want to hold on to these players for the long term. 
Via The Motley Fool
News headline image
September Rally? 3 Healthcare Stocks to Buy Before Liftoff. ↗
The anticipated volume of future healthcare spending makes this a time to look at healthcare stocks to buy for the long term. 
Via InvestorPlace
News headline image
The 3 Best Pharma Stocks to Buy Now: September 2023 ↗
There are pharma stocks to buy for each type of investor. This article explores the best options in the industry. 
Via InvestorPlace
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
57 58 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.